Profil
Joern-Peter Halle is currently a Venture Partner at Biogeneration Management BV since 2024.
Formerly, the role of Chief Strategy Officer was held at Merck KGaA from 2022 to 2024.
The position of Director was held at iOnctura SA. Education includes a doctorate from Universität Konstanz conferred in 1994.
Aktiva positioner av Joern-Peter Halle
| Företag | Position | Start |
|---|---|---|
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Privat kapitalinvesterare | 2024-04-01 |
Tidigare kända positioner av Joern-Peter Halle
| Företag | Position | Slut |
|---|---|---|
| MERCK KGAA | Företagsledare/Principal | 2024-03-01 |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Direktör/Styrelseledamot | - |
Joern-Peter Halles utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität Konstanz
Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management invests in companies located in the United States, Netherlands and Europe. The firm targets companies operating in the fields of biotechnology sectors. It provides financing for pre-seed, seed and early stage capital requirements. It also acts as lead investor. | Finance |
iOnctura SA
iOnctura SA BiotechnologyHealth Technology Develops therapies that extend health span for cancer patients | Health Technology |
















